Health
Waisman Biomanufacturing partners with Heat Biologics to manufacture COVID-19 vaccine – Mirage News
Waisman Biomanufacturing staff operate a centrifuge that allows for cell separation. The UW-Madison biopharmaceutical contract manufacturer is partnering…
Waisman Biomanufacturing staff operate a centrifuge that allows for cell separation. The UW-Madison biopharmaceutical contract manufacturer is partnering with Heat Biologics to produce a COVID-19 vaccine for phase 1 and phase 2 clinical trials. Todd Brown, Media Solutions, UW School of Medicine and Public Health
Waisman Biomanufacturing at the University of Wisconsin-Madison is partnering with Heat Biologics to produce a COVID-19 vaccine for phase 1 and phase 2 clinical trials. Phase 1 trials c…
-
Noosa News21 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Noosa News21 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business14 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today